NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Vale L, Kunonga P, Coughlan D, et al. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model. Southampton (UK): NIHR Journals Library; 2021 Nov. (Health Technology Assessment, No. 25.64.)

Appendix 5Example search strategy for diagnostic accuracy review

#SearchesResults (n)
Melanoma
1exp melanoma/or melanoma*.ti,ab,kw,kf.124,381
2amelanotic.ti,ab,kw,kf.1956
3((lentigo* or lentigin*) adj3 (tumo?r* or cancer* or maligna* or n?evus)).ti,ab,kw,kf.1323
4or/1-3124,778
5(ocular or uveal or iris or cornea or eye or choroidal or ciliary or intraocular).ti.160,371
64 not 5117,550
Diagnostic method
7exp ultrasonography, doppler/or exp ultrasonography, interventional/89,434
8ultrasound.ti,ab,kw,kf.224,479
9ultrason*.ti,ab,kw,kf.154,906
10exp image guided biopsy/4564
11exp Biopsy, Fine-Needle/14,316
12(“fine needle biopsy” or FNB).ti,ab,kw,kf.2199
13(“fine needle aspirat*” or FNA).ti,ab,kw,kf.29,692
14(“fine needle aspiration cytology” or FNAC).ti,ab,kw,kf.8227
15exp Biopsy, Needle/62,995
16“core biopsy”.ti,ab,kw,kf.3971
17or/7-16455,777
Diagnostic test filter
18exp “sensitivity and specificity”/544,996
19(sensitivity or specificity or accuracy).tw.1,228,698
20((predictive adj3 value$) or (roc adj curve$)).tw.123,584
21((false adj positiv$) or false negativ$).tw.71,980
22((observer adj variation$) or (likelihood adj3 ratio$)).tw.15,344
23likelihood function/20,943
24exp mass screening/119,419
25diagnosis, differential/or exp Diagnostic errors/535,465
26di.xs. or du.fs.3,322,576
27or/18-264,663,491
Follow up/surveillance terms
28follow up.ti,ab,kw,kf.872,434
29surveillance.ti,ab,kw,kf.159,164
30monitor*.ti,ab,kw,kf.729,895
31exp Neoplasm Recurrence, Local/di, dg, pc [Diagnosis, Diagnostic Imaging, Prevention & Control]21,379
32exp Recurrence/di, dg, pc [Diagnosis, Diagnostic Imaging, Prevention & Control]8
33recur*.ti,ab,kw,kf.538,847
34exp Neoplasm Metastasis/di, dg, pc [Diagnosis, Diagnostic Imaging, Prevention & Control]8124
35metast*.ti,ab,kw,kf.462,364
36exp Aftercare/177,538
37or/28-362,591,386
386 and 17 and 27 and 37928
39exp animals/not humans.sh.4,548,295
4038 not 39904
Copyright © Queen’s Printer and Controller of HMSO 2021. This work was produced by Vale et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.
Bookshelf ID: NBK575316
Contents